Dilafor Ab

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 37.5

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Gunvor Ekman-Ordeberg (6 out of 6 patents)

Anders Malmström (3 out of 4 patents)

Lena Degling-Wikingsson (3 out of 3 patents)

4. Per-Olov Eriksson (2 out of 4 patents)

5. Erik Yngve Holmer (2 out of 4 patents)

6. Stefan Hansson (1 out of 4 patents)

7. Hans-Peter Ekre (1 out of 3 patents)

8. Ulf Lindahl (1 out of 6 patents)

8 patents: Sort by Forward Citations

1. 12611423 - Medical use of tafoxiparin (2026-04-28),

2. 12502403 - Tafoxiparin for the treatment of preeclampsia (2025-12-23),

3. 12419904 - Medical use of tafoxiparin (2025-09-23),

4. 10023659 - Processes for the production of chemically-modified heparins (2018-07-17),

5. 9475888 - Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use (2016-10-25),

6. 8524688 - Use of sulfated glycosaminoglycans for establishing effective labor in women (2013-09-03),

7. 8207145 - Use of sulfated glycosaminoglycans for establishing effective labor in women (2012-06-26),

8. 7407945 - Use of sulfated glycosaminoglycans for establishing effective labor in women (2008-08-05),

Company Overview

Dilafor Ab is a Swedish biotech company focused on developing treatments for women’s health conditions. Their lead product candidate, tafoxiparin, is aimed at preventing and treating postpartum hemorrhage. Dilafor Ab's innovative approach to drug development and commitment to improving maternal health make them a leader in the field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#26 in Solna

#720 in Sweden

Solna, Sweden

Dilafor Ab

Forward Citations = 2

8 inventors:

Gunvor Ekman-Ordeberg (6 out of 6 patents)

Anders Malmström (3 out of 4 patents)

Lena Degling-Wikingsson (3 out of 3 patents)

4. Per-Olov Eriksson (2 out of 4 patents)

5. Erik Yngve Holmer (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dilafor Ab. Retrieved from https://idiyas.com/company/dilafor-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]